Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)

Clinical trial NCT04447651 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04447651
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Metastatic Solid Tumor SF3B1 Gene Mutation Spliceosome Mutation U2AF1 Gene Mutation SRSF2 Gene Mutation

Start date: 2020-09-17
Primary completion: 2023-05-15
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.